Literature DB >> 22100166

Adverse obstetric outcomes associated with sonographically identified large uterine fibroids.

Valerie I Shavell1, Mili Thakur, Anjali Sawant, Michael L Kruger, Theodore B Jones, Manvinder Singh, Elizabeth E Puscheck, Michael P Diamond.   

Abstract

STUDY
OBJECTIVE: To determine the impact of sonographically identified large uterine fibroids (>5 cm in diameter) on obstetric outcomes.
DESIGN: Retrospective cohort study.
SETTING: University teaching hospital. PATIENT(S): Women with singleton gestations (n = 95) noted to have uterine fibroids on obstetric ultrasonography from September 2009 through April 2010 and age-matched controls (n = 95). INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Obstetric outcomes including short cervix, preterm premature rupture of membranes, and preterm delivery. RESULT(S): Compared to women with no fibroids or small fibroids (≤5 cm), women with large fibroids (>5 cm) delivered at a significantly earlier gestational age (38.6 vs. 38.4 vs. 36.5 weeks). Short cervix, preterm premature rupture of membranes, and preterm delivery were also significantly more frequent in the large fibroid group, and were associated with number of fibroids >5 cm in diameter. Blood loss at delivery was significantly higher in the large fibroid group (486.8 vs. 535.6 vs. 645.1 mL), as was need for postpartum blood transfusion (1.1 vs. 0.0 vs. 12.2%). CONCLUSION(S): Women with large uterine fibroids in pregnancy are at significantly increased risk for delivery at an earlier gestational age compared to women with small or no fibroids, as well as obstetric complications including excess blood loss and increased frequency of postpartum blood transfusion.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22100166     DOI: 10.1016/j.fertnstert.2011.10.009

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  29 in total

1.  Fertility and Pregnancy Outcome after Myoma Enucleation by Minilaparotomy under Microsurgical Conditions in Pronounced Uterus Myomatosus.

Authors:  K Floss; G-J Garcia-Rocha; S Kundu; C S von Kaisenberg; P Hillemanns; C Schippert
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-01       Impact factor: 2.915

Review 2.  Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) Treatment of Symptomatic Uterine Fibroids: An Evidence-Based Analysis.

Authors:  G Pron
Journal:  Ont Health Technol Assess Ser       Date:  2015-03-01

3.  Impact of intramural non-cavity-distorting leiomyoma on placental histopathology and perinatal outcome in singleton live births resulting from in vitro fertilization treatment.

Authors:  Alexander Volodarsky-Perel; Tuyet Nhung Ton Nu; Togas Tulandi; William Buckett; Yaron Gil; Alexandre Machado-Gedeon; Yiming Cui; Jonathan Shaul; Michael H Dahan
Journal:  J Assist Reprod Genet       Date:  2020-06-23       Impact factor: 3.412

Review 4.  The conservative and interventional treatment of fibroids.

Authors:  Alexander Stephan Boosz; Peter Reimer; Matthias Matzko; Thomas Römer; Andreas Müller
Journal:  Dtsch Arztebl Int       Date:  2014-12-22       Impact factor: 5.594

5.  Surgical and Conservative Management of Symptomatic Leiomyomas during Pregnancy: a Retrospective Pilot Study.

Authors:  R Rothmund; F A Taran; B Boeer; M Wallwiener; H Abele; R Campo; D Wallwiener; S Brucker; K Rall
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-04       Impact factor: 2.915

6.  Fibroid tumors are not a risk factor for adverse outcomes in twin pregnancies.

Authors:  Molly J Stout; Anthony O Odibo; Anthony L Shanks; Ryan E Longman; George A Macones; Alison G Cahill
Journal:  Am J Obstet Gynecol       Date:  2012-10-24       Impact factor: 8.661

Review 7.  Leiomyoma: genetics, assisted reproduction, pregnancy and therapeutic advances.

Authors:  Gary Levy; Micah J Hill; Stephanie Beall; Shvetha M Zarek; James H Segars; William H Catherino
Journal:  J Assist Reprod Genet       Date:  2012-05-15       Impact factor: 3.412

8.  The Selective Progesterone Receptor Modulator Ulipristal Acetate Inhibits the Activity of the Glucocorticoid Receptor.

Authors:  Benjamin Small; Charles E F Millard; Edwina P Kisanga; Andreanna Burman; Anika Anam; Clare Flannery; Ayman Al-Hendy; Shannon Whirledge
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

9.  Cesarean Myomectomy: An Experience from a Tertiary Care Teaching Hospital.

Authors:  T Ramya; Shraddha S Sabnis; T V Chitra; Seetha Panicker
Journal:  J Obstet Gynaecol India       Date:  2019-06-03

Review 10.  Uterine Fibroids and Pregnancy: How Do They Affect Each Other?

Authors:  Larissa M Coutinho; Wiviane A Assis; Ananda Spagnuolo-Souza; Fernando M Reis
Journal:  Reprod Sci       Date:  2021-06-17       Impact factor: 2.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.